Pharmacokinetic profile of nomegestrol acetate and 17β-estradiol after multiple and single dosing in healthy women.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Contraception

• Publication date

  2013-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.contraception.2012.07.001PMID 22898360
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DrugSelection Perspectives

  2016cited by this paper
• 20 µg versus >20 µg estrogen combined oral contraceptives for contraception.

  2013cited by this paper
• Efficacy, Safety, and Tolerability of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate and 17&bgr;-Estradiol: A Randomized Controlled Trial

  2012cited by this paper
• Effectiveness of Oral Contraceptive Pills in a Large U.S. Cohort Comparing Progestogen and Regimen

  2011cited by this paper
• 20 µg versus >20 µg estrogen combined oral contraceptives for contraception.

  2011cited by this paper
• Nomegestrol acetate: steroid receptor transactivation profile in Chinese hamster ovary cells and ovulation inhibition in rat and monkey.

  2011cited by this paper
• Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen

  2011cited by this paper
• Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in comparison to one containing levonorgestrel and ethinylestradiol on markers of endocrine function

  2011cited by this paper
• Nomegestrol acetate, a novel progestogen for oral contraception.

  2011cited by this paper
• Effects of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol on ovarian function in comparison to a monophasic combined oral contraceptive containing drospirenone and ethinylestradiol

  2010cited by this paper
• 50 years of “The Pill”: celebrating a golden anniversary

  2010cited by this paper
• Nomegestrol Acetate

  2010cited by this paper
• Pharmacokinetics of an oral contraceptive containing oestradiol valerate and dienogest

  2009cited by this paper
• 20 microg versus >20 microg estrogen combined oral contraceptives for contraception.

  2008cited by this paper
• New progestagens for contraceptive use.

  2006cited by this paper
• Pharmacology of different progestogens: the special case of drospirenone

  2005cited by this paper
• Relationship between sex hormone-binding globulin and pregnancy outcome in women undergoing controlled ovarian hyperstimulation for assisted reproduction.

  2005cited by this paper
• Pharmacology of estrogens and progestogens: influence of different routes of administration

  2005influential reference
• Pharmacological profile of progestins.

  2004cited by this paper
• Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone.

  2004cited by this paper
• Oral contraceptive update: new agents and regimens.

  2004cited by this paper
• Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 μg ethinylestradiol and 3 mg drospirenone

  2004cited by this paper
• Newer progestogens

  2003cited by this paper
• Effect of four different oral contraceptives on various sex hormones and serum-binding globulins.

  2003cited by this paper
• An overview of nomegestrol acetate selective receptor binding and lack of estrogenic action on hormone-dependent cancer cells.

  2003cited by this paper
• The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 microg and ethinylestradiol 15 microg.

  1999cited by this paper
• International clinical experience with a new low-dose, monophasic oral contraceptive containing levonorgestrel 100 microg and ethinyl estradiol 20 microg.

  1999cited by this paper
• Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 micrograms and 35 micrograms estrogen preparations.

  1999cited by this paper
• Efficacy, cycle control, and side effects of low- and lower-dose oral contraceptives: a randomized trial of 20 μg and 35 μg estrogen preparations

  1999cited by this paper
• International clinical experience with a new low-dose, Monophasic oral contraceptive containing levonorgestrel 100 μg and ethinyl estradiol 20 μg

  1999cited by this paper
• Approaches to the replacement of ethinylestradiol by natural 17beta-estradiol in combined oral contraceptives.

  1998cited by this paper
• Single‐Dose Pharmacokinetics of Sublingual Versus Oral Administration of Micronized 17β‐Estradiol

  1997cited by this paper
• Single-dose pharmacokinetics of sublingual versus oral administration of micronized 17 beta-estradiol.

  1997cited by this paper
• Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol.

  1996cited by this paper
• Oral contraceptive containing natural estradiol for premenopausal women.

  1995cited by this paper
• Enzyme immunoassay for nomegestrol acetate in human plasma.

  1993cited by this paper
• Pharmacokinetics of estradiol, free and total estrone, in young women following single intravenous and oral administration of 17 beta-estradiol.

  1993cited by this paper
• Ovulation inhibition with a combined oral contraceptive containing 1 mg micronized 17 beta-estradiol.

  1993cited by this paper
• Pharmacokinetics of percutaneous estradiol: A crossover study using a gel and a transdermal system in comparison with oral micronized estradiol

  1991cited by this paper
• COMPARISON OF THE EFFECTS OF ORAL AND TRANSDERMAL OESTRADIOL ADMINISTRATION ON OESTROGEN METABOLISM, PROTEIN SYNTHESIS, GONADOTROPHIN RELEASE, BONE TURNOVER AND CLIMACTERIC SYMPTOMS IN POSTMENOPAUSAL WOMEN

  1989cited by this paper
• New natural oestradiol/cyproterone acetate oral contraceptive for pre-menopausal women.

  1988cited by this paper
• Effect of nomegestrol acetate, a new 19‐nor‐progesterone derivative, on pituitary‐ovarian function in women

  1987cited by this paper
• The Female Reproductive System

  1983cited by this paper
• Comparison of pharmacodynamic properties of various estrogen formulations.

  1982cited by this paper
• A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens

  1980cited by this paper
• A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception.

  1980cited by this paper
• CLINICAL TRIAL OF A NEW ORAL CONTRACEPTIVE PILL CONTAINING THE NATURAL OESTROGEN 17β‐OESTRADIOL

  1979cited by this paper
• Natural oestrogens for oral contraception.

  1979cited by this paper
• Clinical trial of a new oral contraceptive pill containing the natural oestrogen 17 beta-oestradiol.

  1979cited by this paper
• The natural oestrogenic hormone oestradiol as a new component of combined oral contraceptives.

  1977cited by this paper

• Combined oral contraceptives and pharmacokinetic drug interactions: impact on efficacy and safety.

  2026cites this paper
• A review of the pharmacology, clinical outcomes, and real-world effectiveness, safety, and non-contraceptive effects of NOMAC/E2

  2024influential citation
• Bleeding Patterns of Oral Contraceptives with a Cyclic Dosing Regimen: An Overview

  2022cites this paper
• Randomized study on the effectiveness of nomegestrol acetate plus 17β-estradiol oral contraceptive versus dienogest oral pill in women with suspected endometriosis‑associated chronic pelvic pain

  2022cites this paper
• Unintended pregnancy in users of nomegestrol acetate and 17β-oestradiol (NOMAC-E2) compared with levonorgestrel-containing combined oral contraceptives: final results from the PRO-E2 study

  2021cites this paper
• Does Nomegestrol Acetate Plus 17β-Estradiol Oral Contraceptive Improve Endometriosis-Associated Chronic Pelvic Pain in Women?

  2020cites this paper
• Pharmacokinetics, metabolism and serum concentrations of progestins used in contraception.

  2020cites this paper
• Isolation, synthesis, and cytotoxicity evaluation of two impurities in nomegestrol acetate

  2019cites this paper
• Phase II dose-finding study on ovulation inhibition and cycle control associated with the use of contraceptive vaginal rings containing 17β-estradiol and the progestagens etonogestrel or nomegestrol acetate compared to NuvaRing

  2018cites this paper
• Ultra-performance liquid chromatography-tandem mass spectrometry assay for determination of plasma nomegestrol acetate and estradiol in healthy postmenopausal women.

  2018influential citation
• Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.

  2017cites this paper
• Improvement of Low Sexual Desire Due to Antiandrogenic Combined Oral Contraceptives After Switching to an Oral Contraceptive Containing 17β-Estradiol

  2017cites this paper
• Pooled analysis of two randomized, open-label studies comparing the effects of nomegestrol acetate/17β-estradiol and drospirenone/ethinyl estradiol on bleeding patterns in healthy women.

  2017cites this paper
• Comparing the androgenic and estrogenic properties of progestins used in contraception and hormone therapy.

  2017cites this paper
• Progestins used in endocrine therapy and the implications for the biosynthesis and metabolism of endogenous steroid hormones.

  2017cites this paper
• Contraceptive options for women with premenstrual dysphoric disorder: current insights and a narrative review

  2016cites this paper
• Original research article Prediction of nomegestrol acetate pharmacokinetics in healthy female adolescents and adults by whole-body physiology-based pharmacokinetic modelling and clinical validation ☆

  2016cites this paper
• Prediction of nomegestrol acetate pharmacokinetics in healthy female adolescents and adults by whole-body physiology-based pharmacokinetic modelling and clinical validation.

  2016influential citation
• Fourth-Generation Progestins Inhibit 3β-Hydroxysteroid Dehydrogenase Type 2 and Modulate the Biosynthesis of Endogenous Steroids

  2016cites this paper
• Nomegestrol acetate/17-beta estradiol: a review of efficacy, safety, and patient acceptability

  2015cites this paper
• Comparative analysis of the effects of nomegestrol acetate/17 β-estradiol and drospirenone/ethinylestradiol on premenstrual and menstrual symptoms and dysmenorrhea

  2015cites this paper
• An update on new orally administered contraceptives for women

  2015influential citation
• The challenge presented by progestins in ecotoxicological research: a critical review.

  2015cites this paper
• NOMAC / E 2 versus DRSP / EE on menstrual symptoms

  2015cites this paper
• Progestins for contraception: modern delivery systems and novel formulations.

  2014cites this paper
• Pharmacokinetics, tissue distribution, and excretion of nomegestrol acetate in female rats

  2014influential citation
• An Improved Synthesis of Nomegestrol Acetate

  2014cites this paper
• The Effect of Therapeutic and Supratherapeutic Oral Doses of Nomegestrol Acetate (NOMAC)/17β-Estradiol (E2) on QTcF Intervals in Healthy Women: Results from a Randomized, Double-Blind, Placebo- and Positive-Controlled Trial

  2014cites this paper
• Nomegestrol acetate/estradiol hormonal oral contraceptive and breast cancer risk

  2014cites this paper
• A New Contraceptive Pill Containing 17β-Estradiol and Nomegestrol Acetate

  2013cites this paper
• Interações medicamentosas envolvendo contracetivos hormonais

  2013cites this paper
• Comparison of the pharmacologic and clinical profiles of new combined oral contraceptives containing estradiol

  2013cites this paper
• Nomegestrol acetate-17b-estradiol for oral contraception

  2013cites this paper
• Changing convention in combination oral contraceptives: estradiol and nomegestrol acetate in a monophasic 24/4 regimen

  2013cites this paper
• Preclinical pharmacological profile of nomegestrol acetate, a synthetic 19-nor-progesterone derivative

  2012cites this paper
• Preclinical pharmacological profile of nomegestrol acetate, a synthetic 19-nor-progesterone derivative

  2012cites this paper